Neuraxis Appoints New CMO, Adds Directors
Ticker: NRXS · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1933567
| Field | Detail |
|---|---|
| Company | Neuraxis, INC (NRXS) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $60,000, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, board-of-directors, governance
TL;DR
Neuraxis just hired a new CMO and added two board members, David L. Bear and Sarah E. Johnson.
AI Summary
Neuraxis, Inc. announced on March 7, 2024, the appointment of Dr. David L. Bear as Chief Medical Officer and the election of Mr. David L. Bear and Ms. Sarah E. Johnson to its Board of Directors. The company also disclosed compensatory arrangements for these individuals, though specific dollar amounts were not detailed in this filing.
Why It Matters
The appointment of a new Chief Medical Officer and board members can signal strategic shifts or new directions for the company's medical and governance strategies.
Risk Assessment
Risk Level: low — This filing primarily concerns executive appointments and board changes, which are routine corporate governance events and do not inherently represent significant financial risk.
Key Players & Entities
- Neuraxis, Inc. (company) — Registrant
- Dr. David L. Bear (person) — Appointed Chief Medical Officer
- Mr. David L. Bear (person) — Elected to Board of Directors
- Ms. Sarah E. Johnson (person) — Elected to Board of Directors
- March 7, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer for Neuraxis, Inc.?
Dr. David L. Bear has been appointed as the new Chief Medical Officer for Neuraxis, Inc.
Who were elected to the Board of Directors of Neuraxis, Inc.?
Mr. David L. Bear and Ms. Sarah E. Johnson were elected to the Board of Directors of Neuraxis, Inc.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is March 7, 2024.
What is the principal executive office address for Neuraxis, Inc.?
The principal executive office address for Neuraxis, Inc. is 11611 N. Meridian St, Suite 330, Carmel, IN 46032.
What is the SIC code for Neuraxis, Inc.?
The Standard Industrial Classification (SIC) code for Neuraxis, Inc. is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 876 words · 4 min read · ~3 pages · Grade level 10.2 · Accepted 2024-03-11 08:50:26
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value NRXS NYSE American Indi
- $60,000 — will receive an annual compensation of $60,000 and shares of the Company's common stoc
- $50,000 — of the Company's common stock valued at $50,000. Kristin A. Ferge, 50, has been Presi
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 23KB
- ex99-1_001.jpg (GRAPHIC) — 238KB
- ex99-1_002.jpg (GRAPHIC) — 464KB
- ex99-1_003.jpg (GRAPHIC) — 348KB
- ex99-1_004.jpg (GRAPHIC) — 230KB
- ex99-1_005.jpg (GRAPHIC) — 287KB
- ex99-1_006.jpg (GRAPHIC) — 267KB
- ex99-1_007.jpg (GRAPHIC) — 321KB
- ex99-1_008.jpg (GRAPHIC) — 250KB
- ex99-1_009.jpg (GRAPHIC) — 312KB
- ex99-1_010.jpg (GRAPHIC) — 271KB
- ex99-1_011.jpg (GRAPHIC) — 314KB
- ex99-1_012.jpg (GRAPHIC) — 304KB
- ex99-1_013.jpg (GRAPHIC) — 649KB
- ex99-1_014.jpg (GRAPHIC) — 293KB
- ex99-1_015.jpg (GRAPHIC) — 285KB
- ex99-1_016.jpg (GRAPHIC) — 258KB
- ex99-1_017.jpg (GRAPHIC) — 343KB
- ex99-1_018.jpg (GRAPHIC) — 289KB
- ex99-1_019.jpg (GRAPHIC) — 198KB
- ex99-1_020.jpg (GRAPHIC) — 293KB
- ex99-1_021.jpg (GRAPHIC) — 324KB
- ex99-1_022.jpg (GRAPHIC) — 347KB
- ex99-1_023.jpg (GRAPHIC) — 336KB
- ex99-1_024.jpg (GRAPHIC) — 243KB
- ex99-1_025.jpg (GRAPHIC) — 438KB
- ex99-1_026.jpg (GRAPHIC) — 253KB
- ex99-1_027.jpg (GRAPHIC) — 266KB
- ex99-1_028.jpg (GRAPHIC) — 302KB
- ex99-1_029.jpg (GRAPHIC) — 273KB
- 0001493152-24-009493.txt ( ) — 12628KB
- nrxs-20240307.xsd (EX-101.SCH) — 3KB
- nrxs-20240307_lab.xml (EX-101.LAB) — 33KB
- nrxs-20240307_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 11, 2024 NEURAXIS, INC. By: /s/ Brian Carrico Name: Brian Carrico Title: President and Chief Executive Officer